WuXi AppTec Co., Ltd. (SHA:603259)

Market Cap	168.32B
Revenue (ttm)	39.59B
Net Income (ttm)	11.18B
Shares Out	2.87B
EPS (ttm)	3.24
PE Ratio	15.61
Forward PE	13.65
Dividend	0.98 (1.69%)
Ex-Dividend Date	Jun 26, 2024

Volume	14,539,124
Average Volume	52,763,305
Open	58.80
Previous Close	58.25
Day's Range	58.48 - 59.39
52-Week Range	36.36 - 70.68
Beta	0.84
RSI	52.39
Earnings Date	Apr 28, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.